Changes of biochemical and hemodynamic parameters after erythropoletin administration in pre-End Stage Renal Disease (ESRD) patients

被引:0
|
作者
Moutzouris, DA [1 ]
Stergiopoulou, D [1 ]
Doulgerakis, C [1 ]
Kontozoglou, G [1 ]
Gennadiou-Spantidou, M [1 ]
Lappas, G [1 ]
机构
[1] Livadia Gen Hosp, Dept Cardiol, Livadia, Greece
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:328 / 328
页数:1
相关论文
共 50 条
  • [41] Sevelamer HCL(RENAGEL®) in paediatric patients with end stage renal disease(ESRD)
    Gaydarova, MS
    Anadoliyski, KA
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V94 - V95
  • [42] PHARMACOKINETICS OF ZIDOVUDINE (AZT) IN PATIENTS WITH END STAGE RENAL-DISEASE (ESRD)
    LEW, SQ
    KIMMEL, PL
    LI, PP
    STRAW, J
    BOSCH, JP
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 307 - 307
  • [43] LIPOPROTEIN (A) [LP(A)] IN PATIENTS WITH END-STAGE RENAL-DISEASE (ESRD)
    KOCH, M
    BOLLMANN, S
    KUTKUHN, B
    GRABENSEE, B
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 543 - 543
  • [44] END-STAGE RENAL-DISEASE (ESRD) IN PATIENTS WITH EATING DISORDERS
    ABDELRAHMAN, EM
    MOORTHY, AV
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 410 - 410
  • [45] Cohort review of patients with parathyroid cancer in End Stage Renal Disease (ESRD)
    Zheng, Victoria
    Lee, James
    Parameswaran, Rajeev
    LANGENBECKS ARCHIVES OF SURGERY, 2024, 409 (01)
  • [46] Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease (ESRD)
    Zoccali, Carmine
    Benedetto, Francesco A.
    Mallamaci, Francesca
    Tripepi, Giovanni
    Cutrupi, Sebastiano
    Pizzini, Patrizia
    Malatino, Lorenzo S.
    Bonanno, Graziella
    Seminara, Giuseppe
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 297 - 297
  • [47] DYSFUNCTIONAL HDL FROM PATIENTS WITH END-STAGE RENAL DISEASE (ESRD) RECOVER AFTER SUCCESSFUL RENAL TRANSPLANTATION
    Huang, T.
    Toelle, M.
    Schuchardt, M.
    Wiedon, A.
    Zidek, W.
    van der Giet, M.
    JOURNAL OF HYPERTENSION, 2010, 28 : E427 - E427
  • [48] INVESTIGATION OF THE ELIMINATION OF DABIGATRAN BY HAEMODIALYSIS IN PATIENTS WITH END STAGE RENAL DISEASE (ESRD)
    Haertter, S.
    Trenmmel, M.
    Nehmiz, G.
    Liesenfeld, K.
    Moschetti, V.
    Peters, H.
    Wagner, F.
    Formella, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S32 - S32
  • [49] Medicare expenditures in periods before and after end-stage renal disease (ESRD).
    St Peter, WL
    Khan, SS
    Ebben, JP
    Li, S
    Xue, JL
    Pereira, BJG
    Collins, AJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 621A - 621A
  • [50] GI Symptoms and Quality of Life of End Stage Renal Disease (ESRD) Patients as Opposed to After Kidney Transplantation
    Pakravan, Ali
    Hussan, Hisham
    Vuong, Giao
    Stotts, Matthew
    Bastani, Bahar
    LaBundy, Jennifer
    Philipneri, Marie
    Prather, Charlene
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S389 - S390